Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.59    -0.31 (-10.69%)
Bid:
2.60
Ask:
2.91
Spread: 0.31 (11.923%)
Market Cap: £4.73m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Lighting Division Update

27 Nov 2015 07:00

RNS Number : 1436H
Nanoco Group PLC
27 November 2015
 



 

For immediate release

27 November 2015

 

RNS REACH

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Lighting Division Update

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces the following update on its Lighting Division following the successful launch of the world's first CFQD® Quantum Dot lighting products at the LuxLive industry trade show in London.

 

Nanoco and its partner Marl International, a UK-based pioneer in LED lighting, launched four product groups at LuxLive including light-emitting ceiling tiles, strip lights, down lighters, and grow lights. All of the product groups use Nanoco CFQD® Quantum Dot film, with the thickness of the film and the size of the quantum dots fine-tuned for specific end uses where colour quality is the primary requirement.

 

In the run up to last week's LuxLive trade show, Nanoco was highlighted in the Lux Global Hotlist 2015 of the ten most exciting lighting firms worldwide. The Global Hotlist panel's citation described Nanoco as a producer of "cadmium-free quantum dots which promise near perfect colour rendering from LEDs". In addition, the Orion strip light developed with Marl was listed among the "10 product innovations to look out for" at the LuxLive show.

 

These accolades contributed to a high level of interest in Nanoco and Marl's stand at the show, along with a number of potential new business opportunities.

 

The lighting products for ambient and specialty lighting displayed at the show included light-emitting ceiling tiles that create diffuse, artificial daylight with a colour temperature of 6500k and low power consumption. These tiles have outstanding colour performance and are ideally suited to high end retail, healthcare and commercial applications.

 

The CFQD® Quantum Dot strip lights shown at LuxLive are particularly suited to architectural lighting applications and the down lights offer high end retailers the opportunity to showcase their merchandise under perfect lighting conditions.

 

Two versions of Nanoco and Marl's grow lights for horticultural applications were also showcased at LuxLive. These grow lights benefit from cadmium-free quantum dots tuned to the wavelengths of light needed for plant growth, hence saving energy and creating optimum lighting conditions. Nanoco is continuing to develop this grow light technology, for example by creating quantum dot films for specific types of plants.

 

Michael Edelman, Nanoco's CEO, commented: "We were delighted by the level of interest at LuxLive in the use of our cadmium-free quantum dot technology in lighting applications. We were also excited by the interest in the range of products that we have created alongside our partner Marl International.

 

"LEDs were by far the dominant lighting type at LuxLive, reflecting the compelling attractions of LEDs in the future of lighting. Our technology has the ability to add outstanding colour performance to the other benefits of LEDs, particularly energy efficiency."

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

David Blain, Chief Financial Officer

Caroline Watson, Investor Relations Manager

cwatson@nanocotechnologies.com

 

Tel: + 44 (0) 7799 897357

Canaccord Genuity - Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Neil Patel

Richard Bootle

Steven Tredget

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABFBBTMBATTMA
Date   Source Headline
5th Jun 202611:55 amRNSTR-1: Notification of major holdings
27th May 20267:00 amRNSIntention to delist from London Stock Exchange
20th Apr 20265:37 pmRNSDirector/PDMR Shareholding
20th Apr 20267:00 amRNSInterim Results
13th Apr 20267:00 amRNSNotice of Results
26th Mar 20267:00 amRNSShoei Litigation Conclusion
19th Mar 20267:00 amRNSStay of Shoei Litigation
23rd Feb 20267:00 amRNSShoei Litigation Update
26th Jan 20267:00 amRNSConclusion of CDX process & Directorate changes
15th Jan 20261:08 pmRNSReceipt of Litigation Proceeds
13th Jan 20264:50 pmRNSResult of AGM
12th Jan 20267:00 amRNSLitigation update
9th Dec 20257:00 amRNSBlocklisting Six-Monthly Return
8th Dec 202511:16 amRNSNotice of AGM
27th Nov 20257:00 amRNSResponse to non-infringement claim
26th Nov 20257:00 amRNSAnnual Report and Accounts
20th Nov 20257:00 amRNSLitigation outcome – Settlement agreed
18th Nov 20257:07 amRNSPreliminary Results
13th Nov 20257:00 amRNSNotice of Results
4th Nov 20257:06 amRNSExtension of Joint Development Agreement
15th Oct 20257:00 amRNS-RAwarding of Government Grant
30th Sep 20254:30 pmRNSTotal Voting Rights and Share Capital
8th Sep 20257:00 amRNSIssue of Equity and Director/PDMR Shareholdings
19th Aug 20257:00 amRNSFull Year Trading Update & Director Retirement
9th Jun 20257:00 amRNSBLOCKLISTING SIX-MONTHLY RETURN
28th Apr 202510:48 amRNSJoint Development Agreement
25th Apr 20257:00 amRNSPatent infringement lawsuit against LG
17th Apr 20253:54 pmRNSHigh Court Confirmation of Capital Reduction
15th Apr 20257:00 amRNSInterim Results & Investor Presentation
13th Mar 20257:00 amRNSNotice of Results
21st Jan 20252:20 pmRNSAnnual General Meeting – Voting Results
18th Dec 20248:26 amRNSDirector/PDMR Shareholding
13th Dec 20241:23 pmRNSResult of General Meeting
9th Dec 20247:00 amRNSBlock Listing Six Monthly Return
6th Dec 20246:30 pmRNSNotice of AGM
29th Nov 20247:00 amRNSGlass Lewis and ISS recommendations
28th Nov 20243:23 pmRNSDirector/PDMR Shareholding
28th Nov 20241:25 pmRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNS2024 Annual Report
20th Nov 20247:00 amRNSPreliminary Results
15th Nov 202411:00 amRNSPosting of Circular and Notice of General Meeting
30th Oct 20247:01 amRNSCompletion of Buyback Programme
30th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Oct 20247:00 amRNSReceipt of General Meeting Requisition Notice
23rd Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Oct 20247:00 amRNSAppointment of CEO and Notice of Results
22nd Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.